N
Neumora Therapeutics, Inc. Common Stock
NMRA · NASDAQ · Healthcare · 296M
Price · close
$1.63
+7.59% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
—
Price / net assetsP/B
2.6×
Enterprise value / EBITDAEV/EBITDA
-0.4×
Free cash flow yieldFCF yield
-77.5%
Return on equityROE
-228.1%
Operating margin
—
Net debt / EBITDAbalance-sheet strength
0.8×
Interest coverage
-74.9×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.